All the news Showing 10 of 93 articles from: HCV and coinfectionsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatitis C halved in Spanish people living with HIV in one year due to treatment Keith Alcorn / 27 October 2017 Spain is making dramatic progress towards eliminating hepatitis C in people living with HIV because of widespread use of direct-acting antivirals, Juan Berenguer of Hospital Gregorio Marañón, Madrid, reported on Friday at the ... Rapid fibrosis progression in large proportion of HIV-positive gay men after acute HCV Michael Carter / 11 October 2017 Over a third of HIV-positive gay men develop significant liver fibrosis after an episode of acute hepatitis C virus (HCV) infection, German investigators report in the Journal of Viral Hepatitis. ... People with HIV/HCV co-infection have an increased risk of cardiovascular disease compared to people with HIV alone Michael Carter / 09 October 2017 People with HIV/hepatitis C virus (HCV) co-infection are between a quarter and a third more likely to develop cardiovascular disease compared to people of a similar age with HIV mono-infection, according to the ... Drinking three or more cups of coffee a day halves the risk of dying for people with HIV/HCV co-infection Michael Carter / 03 October 2017 Drinking three or more cups of coffee a day halves the risk of death from any cause for people with HIV/hepatitis C virus (HCV) co-infection, French investigators report in the ... Liver fibrosis speeds up around the menopause in women with HIV and HCV co-infection Michael Carter / 22 August 2017 Menopause is associated with accelerated liver fibrosis in women with HIV and hepatitis C virus (HCV) co-infection, investigators from the United States report in the online edition of Clinical Infectious Diseases. The study showed ... Switching from efavirenz to raltegravir leads to significant improvements in fatty liver disease in people with HIV Michael Carter / 17 August 2017 Switching to raltegravir from efavirenz is associated with significant improvements in liver steatosis for HIV-positive people with non-alcoholic fatty liver disease, Spanish investigators report in the online edition of Clinical ... Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection Liz Highleyman / 26 July 2017 AbbVie's new pangenotypic regimen combining glecaprevir and pibrentasvir cured almost all HIV-positive people with hepatitis C co-infection in the EXPEDITION-2 study, according to a presentation on Monday at the 9th International AIDS Society ... Targeting MSM with HIV: Treatment as Prevention in the Netherlands Healio Hepatology / 18 July 2017 Six-question risk score can identify HIV-positive gay men needing testing for acute hepatitis C Roger Pebody / 13 June 2017 Six questions can identify HIV-positive gay men who are at elevated risk of having acute (recent) hepatitis C infection and who would benefit from further testing, according to a paper ... No Consistent Pattern of HBV Reactivation With Direct-acting Antivirals for HCV Medscape (requires free registration) / 27 April 2017 ← Prev12345...10Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive